Article
Digital Health Platform Engages Patients at Home
An FDA-registered health hub, the platform shows promising early results, including driving patient engagement rates as high as 80%, leading to changes in underlying behaviors affecting medication nonadherence.
Officials with HAP Innovations have announced results from a pilot program of its spencer digital health platform. An FDA-registered health hub, the platform shows promising early results, including driving patient engagement rates as high as 80%, leading to changes in underlying behaviors affecting medication nonadherence.
The spencer digital platform includes a countertop in-home medication dispensing and engagement device, the spencerAssist mobile app for family caregivers, and the spencerCare clinical site for pharmacists and care providers. Pharmacists monitor patient medication and input, and with those insights, care providers can call or schedule a video appointment using spencer.
The spencer-certified pharmacy network currently offers coverage in 32 states as HAP Innovations delivers against orders in multiple markets, including accountable care organizations (ACOs). Spencer will enter the life sciences market later this year as part of a clinical trial protocol.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Donanemab-Azbt Receives FDA Label Update With New Dosing for Alzheimer Disease
